AZD1222
01.13.21
EMA Receives Conditional Marketing Request for AstraZeneca’s COVID-19 VaccineSource: FirstWord
11.30.20
UK Government Asks Regulator to Clear “Temporary Supply” of AstraZeneca’s COVID-19 VaccineSource: FirstWord
10.27.20
AstraZeneca’s COVID-19 Vaccine Produces Robust Immune Response in ElderlySource: FirstWord
10.22.20
Suspected Control Group Participant in AstraZeneca COVID-19 Vaccine Study Dies; Trial ContinuesSource: FirstWord
10.21.20
Sources Say US Study of AstraZeneca’s COVID-19 Vaccine May Restart This WeekSource: FirstWord
10.02.20
EMA Starts Rolling Review of AstraZeneca’s COVID-19 Vaccine Candidate AZD1222Source: FirstWord
09.17.20
Oxford Says AstraZeneca Trial Illnesses May Not Be Linked to COVID-19 VaccineSource: FirstWord
09.16.20
FDA Probes Whether to Allow AstraZeneca to Resume COVID-19 Vaccine Trial in USSource: FirstWord